Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|August 1, 1990
Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeastsR A Cook, K A McIntyre, J N GalgianiThe American Journal of Medicine|March 1, 1993
Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic areaN M Ampel, C L Dols, J N GalgianiJournal of Clinical Microbiology|March 1, 1996
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcomeM A Ghannoum, J H Rex, J N GalgianiReviews of Infectious Diseases|November 1, 1989
Coccidioidomycosis: clinical updateN M Ampel, M A Wieden, J N GalgianiDiagnostic Microbiology and Infectious Disease|October 1, 1994
Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratoriesA Espinel-Ingroff, L Steele-Moore, J N GalgianiReviews of Infectious Diseases|July 1, 1980
Therapy of disseminated or pulmonary coccidioidomycosis with ketoconazoleC Brass, J N Galgiani, S C Campbell, et al.The Journal of Infectious Diseases|January 7, 1999
Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturationT Peng, K I Orsborn, M J Orbach, et al.Infection and Immunity|January 1, 1987
Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functionsR L Friedman, R L Fiederlein, L Glasser, et al.Infection and Immunity|July 23, 1998
Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in miceT N Kirkland, F Finley, K I Orsborn, et al.Archives of Internal Medicine|March 1, 1982
Coccidioidomycosis in renal replacement therapyI M Cohen, J N Galgiani, D Potter, et al.Pageof 13